H.R. 3010, Regulatory Accountability Act of 2011. H.R. 2632, Life Sciences Jobs and Investment Act of 2011. Oversight of implementation of the America Invents Act. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011
H.R. 3988, Generic Drug and Biosimilar User Fee Act of 2012
S. 3187, FDA Safety and Innovation Act
H.R. 5998, USPSTF Transparency and Accountability Act H.R. 6544, Manufacturing Innovation in America Act
H.R. 6160, Stop Tampering of Prescription Pills Act
H.R. 436, Health Care Cost Reduction Act regarding medical device excise tax repeal
Issues relating to bioequivalence and related administrative procedures
Issues relating to DEA quotas for controlled substances
Oversight of DEA
Issues relating to prescription drug abuse
Issues relating to incentives for tamper-resistant formulations
GOV - Government Issues TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ENDO INTERNATIONAL
1400 Atwater Drive, Malvern, PA, 19355, US
JAMES BRIAN MUNROE BRENT J FISK CANDIE PHIPPS JAMES BRIAN MUNROE BRENT J FISK CANDIE PHIPPS JAMES BRIAN MUNROE BRENT J FISK CANDIE PHIPPS JAMES BRIAN MUNROE BRENT J FISK CANDIE PHIPPS